InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+0.1%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the complete record of transactions filed by Shimer Julie Ann, 董事. Director active across 5 companies, notably MASIMO CORP. Aggregated, 13 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €9k. Activity tracked since 27 May 2021. The latest transaction was disclosed on 27 July 2026 (Disposition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Shimer Julie Ann
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
50,090 股@ US$25.000.11% mcap99.2% 占其流量Common StockSEC:0001606498-26-000109:0
12,003 股0Common StockSEC:0001606498-25-000008:0
500 股@ US$19.85100.0% 占其流量Common StockSEC:0001606498-24-000043:0
标准退出：2024年6月9日 (T+90)
8,378 股0Common StockSEC:0001606498-24-000008:0
1,435 股Common StockSEC:0000937556-23-000123:0
36,021 股Common StockSEC:0001251769-23-000021:0
7,008 股0Common StockSEC:0001606498-23-000005:0
14,224 股0Common StockSEC:0001251769-22-000057:0
922 股@ US$139.340.0013% mcap31.0% 占其流量Common StockSEC:0000937556-22-000105:0
5,354 股0Common StockSEC:0001606498-22-000002:0
3,888 股0Common StockSEC:0001251769-21-000080:0
749 股@ US$216.7952.7% 占其流量Common StockSEC:0000937556-21-000106:0
4,274 股Common StockSEC:0001209191-16-089560:0
13 条申报中的 13 条
About Shimer Julie Ann
Shimer Julie Ann is Administrateur and is listed as a director at Avanos Medical, INC., MASIMO CORP, Apollo Endosurgery, Inc. and Halyard Health, Inc. She has 13 filings in total, and across the 13 sampled filings from 2016-01-06 to 2026-07-28, the volumes are 9070 EUR in buys and 1097597 EUR in sells, with the dominant transaction nature being Attribution.
